Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
CNBC Markets · Fri, 06 Nov 2026 12:43:28 GMT
Read the full story at CNBC Markets ↗OmniFin Portal's take
Excerpt from CNBC Markets: “The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.”
Rule-based headline sentiment: Bullish
More Stocks headlines
‘It feels like he’s quietly building a separate life’: My husband inherited $500,000, but he refuses to spend it on our home— MarketWatchOpenAI bugging suspect Alfozan pleads not guilty— CNBC MarketsTrump says Stephen Miller to replace Susie Wiles as White House chief of staff— CNBC MarketsMy 93-year-old father changed his will at the 11th hour, leaving my brother his entire $500,000 estate. Can I challenge it?— MarketWatch
New to the fundamentals behind stories like this?
OmniFin Academy covers money basics, risk management, and reading markets — free, self-paced, no sign-up required.
Start OmniFin Academy →